Drew Adams

Case Western Reserve University School of Medicine
Department of Genetics and Genome Sciences, Small-Molecule Drug Development Core
Cleveland USA Papers:
211 Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies